Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization
NDAQ:PCRX) Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization ...
TMCnet14d
Pacira BioSciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a ...
Mena FN15d
Pacira Biosciences To Present At The 43Rd Annual J.P. Morgan Healthcare Conference
ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and ioverao ...
The Globe and Mail21d
U.S. FDA approves injectable version of cancer drug from Bristol Myers Squibb
The U.S. Food and Drug Administration said on Friday that it has approved an injectable version of Bristol Myers Squibb’s BMY-N blockbuster cancer drug, Opdivo. Opdivo is part of a class of ...
deped21d
DepEd pushes for learning continuity amid disasters, updates class suspension guidelines
PASIG CITY, 27 December 2024 – The Department of Education (DepEd) has updated measures to strengthen the preparedness of schools for disasters and other emergencies, emphasizing the importance of ...
Mena FN29d
Clearside Biomedical Announces Publication Of Critical Insights Into Retinal Drug Development In The Peer-Reviewed Scientific Journal, Eye
Clearside developed and gained approval for its first product, XIPERE ® (triamcinolone acetonide injectable suspension for suprachoroidal use, which is available in the U.S. through a commercial ...